Back to news

Octave Specialty Group Reports Third Quarter 2026 Results

Business Wire•09/11/2026•16:05 ET
0

Key Highlights

  • ➤Total revenue rose 28% to $85.3 million year over year
  • ➤Insurance Distribution revenue increased 35% to $58 million; organic growth reached 23%
  • ➤Everspan net income reached $1.3 million versus $(0.1) million loss
  • ➤Consolidated Adjusted EBITDA improved to $3.3 million from $(2.9) million
  • ➤Everspan agreed to sell Providence Washington Insurance Company’s redundant admitted shell

Expert Statements

Claude LeBlanc, President and Chief Executive Officer of Octave

“Octave delivered a solid third quarter, with continued growth in our Insurance Distribution business and further progress at Everspan, despite a P&C market that has become more competitive as the year has progressed.”

Claude LeBlanc, President and Chief Executive Officer of Octave

“While we expect market softening to continue into 2027, we believe that our operating model was built to perform through market cycles, and Octave is well positioned to deliver sustained, profitable growth toward our long-term goals.”

Claude LeBlanc, President and Chief Executive Officer of Octave

“In the third quarter, we grew our Insurance Distribution revenue 35%, including organic revenue growth of 23%.”

Claude LeBlanc, President and Chief Executive Officer of Octave

“This strong organic growth, well ahead of the broader industry, is consistent with our seasonally adjusted third quarter plan and reflects the strength of our purposely diversified portfolio strategy and the strong embedded value of our scaling MGA incubator.”

Claude LeBlanc, President and Chief Executive Officer of Octave

“Everspan's results continue to reflect the repositioning of its growing programs business.”

Claude LeBlanc, President and Chief Executive Officer of Octave

“During the third quarter, the combined ratio improved meaningfully from the prior-year period.”

Claude LeBlanc, President and Chief Executive Officer of Octave

“Subsequent to quarter end, Everspan entered into an agreement to sell its redundant admitted shell company, Providence Washington Insurance Company, which is expected to help simplify its operating structure and further strengthen its capital base.”

* Net loss to shareholders totaled $(4.2) million, compared to $(5.4) million in 3Q25

* Adjusted EBITDA to shareholders totaled $8.3 million, compared to $6.0 million in 3Q25

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in